Literature DB >> 20683687

Development and characterization of mucoadhesive in situ nasal gel of midazolam prepared with Ficus carica mucilage.

Shyamoshree Basu1, Amal Kumar Bandyopadhyay.   

Abstract

The objective of the present study was to prepare mucoadhesive in situ nasal gels with mucilage isolated from fig fruits (Ficus carica, family: Moraceae) containing midazolam hydrochloride. Nasal gels of midazolam were prepared using three different concentrations (0.5%, 1.0% and 1.5% w/v) of F. carica mucilage (FCM) and synthetic polymers (hydroxypropylmethyl cellulose and Carbopol 934). Evaluation of FCM showed that it was as safe as the synthetic polymers for nasal administration. In situ gels were prepared with mixture Pluronic F127 and mucoadhesive agents. Evaluation of the prepared gels was carried out, including determination of viscosity, texture profile analysis and mucoadhesive strength. In vitro drug permeation study was conducted with the gels prepared with and without permeation enhancer (0.5% w/v sodium taurocholate) using excised goat nasal mucosa. In vitro permeation profiles were evaluated, and histological study of nasal mucosae before and after permeation study was also conducted to determine histological change, if any. In vivo experiments conducted in rabbits further confirmed that in situ nasal gels provided better bioavailability of midazolam than the gels prepared from synthetic mucoadhesive polymers. It was observed that the nasal gel containing 0.5% FCM and 0.5% sodium taurocholate exhibited appropriate rheological, mechanical and mucoadhesive properties and showed better drug release profiles. Moreover, this formulation produced no damage to the nasal mucosa that was used for the permeation study, and absolute bioavailability was also higher compared to gels prepared from synthetic polymers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20683687      PMCID: PMC2974119          DOI: 10.1208/s12249-010-9477-x

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  32 in total

1.  Nasal mucociliary clearance as a factor in nasal drug delivery.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1998-01-05       Impact factor: 15.470

2.  Nasal/buccal midazolam use in the community.

Authors:  M T Wilson; S Macleod; M E O'Regan
Journal:  Arch Dis Child       Date:  2004-01       Impact factor: 3.791

Review 3.  Nasal drug delivery: new developments and strategies.

Authors:  Lisbeth Illum
Journal:  Drug Discov Today       Date:  2002-12-01       Impact factor: 7.851

Review 4.  Nasal route and drug delivery systems.

Authors:  Selcan Türker; Erten Onur; Yekta Ozer
Journal:  Pharm World Sci       Date:  2004-06

5.  Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial.

Authors:  R C Scott; F M Besag; B G Neville
Journal:  Lancet       Date:  1999-02-20       Impact factor: 79.321

6.  Thermoreversible-mucoadhesive gel for nasal delivery of sumatriptan.

Authors:  Rita J Majithiya; Pradip K Ghosh; Manish L Umrethia; Rayasa S R Murthy
Journal:  AAPS PharmSciTech       Date:  2006-08-04       Impact factor: 3.246

7.  Effect of Pluronic gels on the rectal absorption of indomethacin in rabbits.

Authors:  S Miyazaki; T Nakamura; C Yokouchi; M Takada
Journal:  Chem Pharm Bull (Tokyo)       Date:  1987-03       Impact factor: 1.645

8.  Pluronic F-127 gels as a vehicle for topical administration of anticancer agents.

Authors:  S Miyazaki; S Takeuchi; C Yokouchi; M Takada
Journal:  Chem Pharm Bull (Tokyo)       Date:  1984-10       Impact factor: 1.645

9.  Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study.

Authors:  E Lahat; M Goldman; J Barr; T Bistritzer; M Berkovitch
Journal:  BMJ       Date:  2000-07-08

10.  Midazolam pharmacokinetics following intravenous and buccal administration.

Authors:  R Schwagmeier; S Alincic; H W Striebel
Journal:  Br J Clin Pharmacol       Date:  1998-09       Impact factor: 4.335

View more
  13 in total

1.  Intranasal In Situ Gel of Apixaban-Loaded Nanoethosomes: Preparation, Optimization, and In Vivo Evaluation.

Authors:  Ahmed A El-Shenawy; Reda A Mahmoud; Essam A Mahmoud; Mohamed S Mohamed
Journal:  AAPS PharmSciTech       Date:  2021-05-04       Impact factor: 3.246

2.  Chlorpheniramine maleate containing chitosan-based nanoparticle-loaded thermosensitive in situ gel for management in allergic rhinitis.

Authors:  Manish Kumar; Pooja Upadhayay; Ravi Shankar; Monika Joshi; Shailendra Bhatt; Anuj Malik
Journal:  Drug Deliv Transl Res       Date:  2019-12       Impact factor: 4.617

3.  Thermoreversible nanoethosomal gel for the intranasal delivery of Eletriptan hydrobromide.

Authors:  Santosh Shelke; Sadhana Shahi; Kiran Jadhav; Dinesh Dhamecha; Roshan Tiwari; Hemlata Patil
Journal:  J Mater Sci Mater Med       Date:  2016-04-18       Impact factor: 3.896

4.  Development of in vitro models to demonstrate the ability of PecSys®, an in situ nasal gelling technology, to reduce nasal run-off and drip.

Authors:  Jonathan Castile; Yu-Hui Cheng; Ben Simmons; Michael Perelman; Alan Smith; Peter Watts
Journal:  Drug Dev Ind Pharm       Date:  2012-07-17       Impact factor: 3.225

5.  Preparation and characterisation of mucoadhesive nasal gel of venlafaxine hydrochloride for treatment of anxiety disorders.

Authors:  Shyamoshree Basu; S Maity
Journal:  Indian J Pharm Sci       Date:  2012-09       Impact factor: 0.975

6.  Intranasal delivery of chitosan nanoparticles for migraine therapy.

Authors:  Neha Gulati; Upendra Nagaich; Shubhini A Saraf
Journal:  Sci Pharm       Date:  2013-04-14

7.  Optimization of Thermoreversible In Situ Nasal Gel of Timolol Maleate.

Authors:  Swati Jagdale; Nirupama Shewale; Bhanudas S Kuchekar
Journal:  Scientifica (Cairo)       Date:  2016-05-16

Review 8.  Smart Polymers in Nasal Drug Delivery.

Authors:  Ankita Chonkar; Usha Nayak; N Udupa
Journal:  Indian J Pharm Sci       Date:  2015 Jul-Aug       Impact factor: 0.975

9.  Intra Nasal In situ Gelling System of Lamotrigine Using Ion Activated Mucoadhesive Polymer.

Authors:  Asha Paul; K M Fathima; Sreeja C Nair
Journal:  Open Med Chem J       Date:  2017-12-29

10.  Intranasally administered in situ gelling nanocomposite system of dimenhydrinate: preparation, characterization and pharmacodynamic applicability in chemotherapy induced emesis model.

Authors:  Sara S Barakat; Maha Nasr; Rania F Ahmed; Sabry S Badawy; Samar Mansour
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.